Caixin
Caixin Global – Latest China News & Headlines

Home >

ABOUT US

CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

LATEST
Ping An-Affiliated Fintech Firm OneConnect Raises Capital from New Share Sale As It Eyes Global Expansion
Pompeo Hints At ‘Broader’ Ban on Chinese Apps After Trump’s Executive Orders Targeting TikTok and WeChat
Trending in China: Merchants and Netizens Forced to Pick Sides in Fight Between Delivery Firms
Baidu-Backed Video Streamer iQiyi Probed by U.S. Regulator After Short Seller’s Report
AI Unicorn SenseTime Is Said to Mull Hong Kong, China IPO
Huawei Copies Korean Rivals by Manufacturing Own Display Driver Integrated Chips
JOYY’s Livestreaming Revenue Up 40% in Second Quarter of 2020
Trending in China: ‘Mukbangs’ Under Fire in China Amid High Level Food Waste Campaign
Trending in China: How Will the Chinese Diaspora Survive a WeChat Ban In U.S.?
Online Platform JD.com Buys into Bricks and Mortar Convenience Store Chain
China Unicom Profits Rise in First Half, Stock Soars
ByteDance in Talks with Indian Conglomerate Over TikTok Amid Layoff Fears
Alibaba’s Zhang Yong Tops 2020 Forbes China Best CEOs List
Trending: Family Feud Raises Big Questions Over Succession in China’s Multi-Million “Family” Businesses
Shanghai-Listed Foxconn Internet’s Cloud Service Sales Up 4% in First Half of 2020
U.S.-Listed Chinese Companies Nio and Huya Have Something to Cheer About
Apple Edges Huawei Out of No. 1 in Quarterly Tablet Shipments
Chinese Finance Platform Lufax Files for U.S. IPO of up to $3 Billion
China Mainland Leads U.S. in Fortune Global 500 Companies But Trails in Profitability
Trending in China: Tencent – Fighting Youth Unemployment or Enemy of Older Workers?
Genome Giant BGI Gets Regulator Approval to Sell Coronavirus Test Kits

By Ding Yi / Jan 29, 2020 12:38 PM / Business & Tech

1

China has approved for sale three medical products developed by genomics company BGI Group, amid efforts to combat the coronavirus outbreak that is known to have infected more than 5,900 people and been linked to over 130 deaths.

The approved products, including two virus detection kits and a sequencing system, will help enhance the country’s ability to prevent and control the spread of the disease, BGI said in a WeChat post on Monday.

According to BGI, one of their test kits is able to identify the novel coronavirus in about three hours, while the other kit can assist doctors to differentiate and diagnose infections caused by the novel coronavirus and those caused by other respiratory pathogens.

The approved sequencing system should be able to provide a great deal of data for analyzing the evolution of the new virus, BGI added.

BGI said that it will send the first batch of 100,000 test kits to the country's worst hit regions. The Shenzhen-listed company has also reached agreements with several countries including Brunei, Thailand and Nigeria to supply them with test kits.

Contact reporter Ding Yi (yiding@caixin.com)

Related: Chinese Genome Sequencing Firm to Supply Tech to Abu Dhabi Personalized Health Care Project


Share this article
Open WeChat and scan the QR code